Aptaas Pharmaceuticals Private Limited
About Aptaas Pharmaceuticals Private Limited
Data last updated:
Aptaas Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 03 May 2013.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2013PTC251521.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Poonam Devi and Deepak Kumar.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at H – 16/104 Ground Floor Sangam Vihar, New Delhi, Delhi, India – 110062.
As per the financials filed for FY 2018, the company reported a revenue of ₹4.25 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹29,761 (net margin -7%) and EBITDA of -₹26,752 (EBITDA margin -6.3%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH – 16/104 Ground Floor Sangam Vihar, New Delhi, Delhi, India – 110062
- IndustryTrading, Wholesale, Specialty
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aptaas Pharmaceuticals Private Limited
The main business activity of Aptaas Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aptaas Pharmaceuticals Private Limited FY 2018 filings available
Aptaas Pharmaceuticals Private Limited reported revenue of ₹4.25 Lakh (down 6% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR) of Aptaas Pharmaceuticals Private Limited
Revenue fell 6% in the latest year. EBITDA rose 63% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Aptaas Pharmaceuticals Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹26,752 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹29,761 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Aptaas Pharmaceuticals Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -6.3% | •••• | •••• | •••• |
| Net Profit Margin | -7% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aptaas Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Aptaas Pharmaceuticals Private Limited
Aptaas Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Kumar | Additional Director | 21 Dec 2018 | 7 Years 10 Months | As last reported |
| Poonam Devi | Director | 08 Jun 2019 | 7 Years 4 Months | As last reported |
Peer Comparison of Aptaas Pharmaceuticals Private Limited
Aptaas Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brizwell Pharmaceuticals Private Limited | ₹4.29 Lakh (FY 2024) | •••• | •••• | •••• | Secunderabad, Telangana, India | |
| True Pill Pharmaceuticals Private Limited | ₹4.28 Lakh (FY 2024) | •••• | •••• | 132.0% | •••• | Bulandshahar, Uttar Pradesh, India |
| Medwock Pharmaceuticals Private Limited | ₹4.28 Lakh (FY 2020) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Prophends Pharmaceuticals (OPC) Private Limited | ₹4.26 Lakh (FY 2025) | •••• | •••• | 55.0% | •••• | Patna, Bihar, India |
| Glorywarrior Pharmaceuticals (OPC) Private Limited | ₹4.26 Lakh (FY 2022) | •••• | •••• | •••• | Ratnagiri, Maharashtra, India | |
| Aptaas Pharmaceuticals Private Limited this company | ₹4.25 Lakh (FY 2018) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
| Heivero Pharmaceuticals Limited | ₹4.25 Lakh (FY 2018) | •••• | •••• | •••• | Uttar Pradesh, India | |
| Sunchoice Pharmaceuticals Private Limited | ₹4.24 Lakh (FY 2024) | •••• | •••• | -5.0% | •••• | Moradabad, Uttar Pradesh, India |
| Ebullition Pharmaceuticals Private Limited | ₹4.23 Lakh (FY 2022) | •••• | •••• | -46.0% | •••• | New Delhi, Delhi, India |
| Smark Pharmaceuticals Private Limited | ₹4.23 Lakh (FY 2025) | •••• | •••• | -2.0% | •••• | Uttar Pradesh, India |
| Rabindra Pharmaceuticals Private Limited | ₹4.22 Lakh (FY 2025) | •••• | •••• | -60.0% | •••• | Muzaffarpur, Bihar, India |
Peers are the five companies nearest above and the five nearest below Aptaas Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Aptaas Pharmaceuticals Private Limited
Aptaas Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aptaas Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Aptaas Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aptaas Pharmaceuticals Private Limited
Aptaas Pharmaceuticals Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Deepu Biswas ceased to be Director on 08 Jun 2019.
Credit Ratings, Litigation & Regulatory Alerts for Aptaas Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aptaas Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aptaas Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aptaas Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aptaas Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aptaas Pharmaceuticals Private Limited
Aptaas Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Aptaas Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in wholesale, within the trading industry. It was incorporated on 03 May 2013 and is registered under CIN U51909DL2013PTC251521. The company has been struck off by the Registrar of Companies and is no longer operational.
Aptaas Pharmaceuticals had 2 directors:
- Deepak Kumar - Additional Director
- Poonam Devi - Director
The CIN (Corporate Identification Number) of Aptaas Pharmaceuticals is U51909DL2013PTC251521. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Aptaas Pharmaceuticals is at H – 16104 Ground Floor Sangam Vihar, New Delhi, Delhi, India – 110062.
Aptaas Pharmaceuticals was incorporated on 03 May 2013. It is registered with the Registrar of Companies, Delhi.
Aptaas Pharmaceuticals reported revenue of ₹4.25 Lakh for FY 2018 (down 6% YoY).
Aptaas Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Aptaas Pharmaceuticals reported a net loss of ₹29,761 (net margin -7%) and EBITDA of -₹26,752 (EBITDA margin -6.3%) for FY 2018, as per its filed financial statements.
Aptaas Pharmaceuticals operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.
No. Aptaas Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.